Iterum Therapeutics PLC expected to post earnings of 12 cents a share - Earnings Preview

Iterum Therapeutics

10/11/2021 13:59

* Iterum Therapeutics PLC  ITRM.OQ   ITRM.O  is expected to show
no change in quarterly revenue when it reports  results on
November 12. 
​* Refinitiv's mean analyst estimate for Iterum Therapeutics PLC
is for earnings of 12 cents per share. For the same quarter last
year, the company reported a loss of 60 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Iterum
Therapeutics PLC is $1​, about 41.8% above​ its last closing
price of $0.58. ​​​
This summary was machine generated November 10 at 13:59 GMT. 
All figures in US dollars  unless otherwise stated